We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+7.79%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$34.8B
AUM Growth
+$2.35B
(+7.2%)
Cap. Flow
+$319M
Cap. Flow
% of AUM
0.92%
Top 10 Holdings %
Top 10 Hldgs %
12.19%
Holding
786
New
104
Increased
253
Reduced
218
Closed
111
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ONXX
ONYX PHARMACEUTICALS INC
ONXX
|
+$336M |
| 2 |
Amgen
AMGN
|
+$176M |
| 3 |
Lockheed Martin
LMT
|
+$140M |
| 4 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$131M |
| 5 |
Trane Technologies
TT
|
+$129M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
POT
Potash Corp Of Saskatchewan
POT
|
+$172M |
| 2 |
RTN
Raytheon Company
RTN
|
+$154M |
| 3 |
Textron
TXT
|
+$126M |
| 4 |
NWSA
NEWS CORPORATION CL-A
NWSA
|
+$109M |
| 5 |
Boeing
BA
|
+$107M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.87% |
| 2 | Industrials | 11.7% |
| 3 | Technology | 10.51% |
| 4 | Financials | 10.51% |
| 5 | Consumer Staples | 9.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Apple
AAPL
$4.72T
| $657M | 1.89% |
38,610,208
+707,000
| +2% | +$11.7M |
|
|
ONXX
2
DELISTED
ONYX PHARMACEUTICALS INC
ONXX
| $512M | 1.47% |
4,109,042
+2,650,000
| +182% | +$336M |
|
3
ExxonMobil
XOM
$650B
| $437M | 1.26% |
5,078,515
-120,000
| -2% | -$10.8M |
|
4
Philip Morris
PM
$298B
| $415M | 1.19% |
4,794,237
-75,000
| -2% | -$6.56M |
|
5
Honeywell
HON
$78B
| $389M | 1.12% |
5,212,897
+629,239
| +14% | +$46.7M |
|
6
Coca-Cola
KO
$349B
| $384M | 1.1% |
10,141,888
-65,000
| -0.6% | -$2.57M |
|
7
Microsoft
MSFT
$2.83T
| $378M | 1.09% |
11,347,355
+146,000
| +1% | +$4.8M |
|
8
Bristol-Myers Squibb
BMY
$126B
| $364M | 1.05% |
7,854,858
-2,180,000
| -22% | -$95.7M |
|
9
GE Aerospace
GE
$362B
| $353M | 1.02% |
3,086,291
+240,180
| +8% | +$27.5M |
|
10
Alphabet (Google) Class C
GOOG
$3.89T
| $349M | 1% |
16,019,983
-923,448
| -5% | -$20.4M |
|
11
JPMorgan Chase
JPM
$930B
| $331M | 0.95% |
6,397,707
-200,000
| -3% | -$10.7M |
|
12
Berkshire Hathaway Class B
BRK.B
$1.06T
| $308M | 0.88% |
2,711,277
-2,716
| -0.1% | -$313K |
|
13
Chevron
CVX
$387B
| $304M | 0.87% |
2,503,968
+180,000
| +8% | +$22.1M |
|
14
Wells Fargo
WFC
$261B
| $287M | 0.83% |
6,948,688
-1,185,000
| -15% | -$50.6M |
|
|
MON
15
DELISTED
Monsanto Co
MON
| $285M | 0.82% |
2,733,408
-1,025,000
| -27% | -$103M |
|
16
IBM
IBM
$195B
| $282M | 0.81% |
1,591,688
-30,961
| -2% | -$5.63M |
|
17
Puma Biotechnology
PBYI
$408M
| $281M | 0.81% |
5,242,519
| – | – |
|
18
Johnson & Johnson
JNJ
$624B
| $267M | 0.77% |
3,082,054
+535,000
| +21% | +$48M |
|
|
19
Trane Technologies
TT
$106B
| $262M | 0.75% |
5,053,524
+2,636,156
| +109% | +$129M |
|
|
APC
20
DELISTED
Anadarko Petroleum
APC
| $253M | 0.73% |
2,715,384
+510,000
| +23% | +$46.4M |
|
|
ESV
21
DELISTED
Ensco Rowan plc
ESV
| $245M | 0.7% |
1,138,572
+451,977
| +66% | +$104M |
|
22
Gilead Sciences
GILD
$162B
| $244M | 0.7% |
3,876,994
-957,000
| -20% | -$57.2M |
|
23
Citigroup
C
$221B
| $241M | 0.69% |
4,961,888
+355,000
| +8% | +$17.9M |
|
24
General Dynamics
GD
$103B
| $238M | 0.68% |
2,718,273
+467,854
| +21% | +$39.7M |
|
25
Walmart Inc
WMT
$863B
| $234M | 0.67% |
9,505,686
+1,515,000
| +19% | +$38.2M |
|
Similar funds
Adage Capital Partners's Q3 2013 Portfolio in Review
As of Q3 2013, Adage Capital Partners held 786 positions worth $34.8B, up 7.2% from $32.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Adage Capital Partners's Q3 2013 filing shows 104 new, 253 increased, 218 reduced and 111 closed positions. Its largest new stake was Twenty-First Century Fox, Inc. Class A: 4,161,090 shares worth $139M. The largest sale was Potash Corp Of Saskatchewan, an estimated $172M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 14% a quarter earlier, followed by Industrials and Technology.
- Adage Capital Partners's largest Q3 2013 buy was Twenty-First Century Fox, Inc. Class A: 4,161,090 shares worth $139M.
- Adage Capital Partners added most to ONYX PHARMACEUTICALS INC in Q3 2013, an estimated $336M increase.
- Adage Capital Partners's biggest Q3 2013 reduction was Potash Corp Of Saskatchewan, cutting an estimated $172M.
- Adage Capital Partners fully exited Raytheon Company in Q3 2013, selling an estimated $154M.
- Adage Capital Partners's ten largest holdings make up 12% of its $34.8B portfolio in Q3 2013.
- Adage Capital Partners opened 104 new positions and closed 111 in Q3 2013.
- Adage Capital Partners's portfolio value rose 7.2% quarter-over-quarter to $34.8B.
Based on Adage Capital Partners's 13F filing for Q3 2013, filed 14 Nov 2013.